Novel Treatment of Experimental Autoimmune Prostatitis by Nanoparticle-Conjugated Autoantigen Peptide T2

[1]  P. Santamaria,et al.  Nanoparticle‐based approaches to immune tolerance for the treatment of autoimmune diseases , 2018, European journal of immunology.

[2]  L. Zhang,et al.  Establishment of experimental autoimmune prostatitis model by T2 peptide in aluminium hydroxide adjuvant , 2018, Andrologia.

[3]  A. Ihsan,et al.  Comprehensive overview of prostatitis. , 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[4]  M. L. Breser,et al.  Immunological Mechanisms Underlying Chronic Pelvic Pain and Prostate Inflammation in Chronic Pelvic Pain Syndrome , 2017, Front. Immunol..

[5]  G. Wang,et al.  A novel mouse model of chronic prostatitis/chronic pelvic pain syndrome induced by immunization of special peptide fragment with aluminum hydroxide adjuvant. , 2017, Immunology letters.

[6]  A. Ihsan,et al.  Establishment of a rat model of chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS) induced by immunization with a novel peptide T2. , 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[7]  D. Shoskes,et al.  Chronic prostatitis/chronic pelvic pain syndrome: a review of evaluation and therapy , 2016, Prostate Cancer and Prostatic Diseases.

[8]  T. Donner,et al.  Interleukin-10 paradox: A potent immunoregulatory cytokine that has been difficult to harness for immunotherapy. , 2015, Cytokine.

[9]  A. Doble,et al.  Diagnosis and treatment of chronic bacterial prostatitis and chronic prostatitis/chronic pelvic pain syndrome: a consensus guideline , 2015, BJU international.

[10]  S. Miller,et al.  Harnessing nanoparticles for immune modulation , 2015, Trends in Immunology.

[11]  A. Schaeffer,et al.  Immune mediators of chronic pelvic pain syndrome , 2014, Nature Reviews Urology.

[12]  S. Miller,et al.  A Biodegradable Nanoparticle Platform for the Induction of Antigen-Specific Immune Tolerance for Treatment of Autoimmune Disease , 2014, ACS nano.

[13]  Douglas M. Smith,et al.  Applications of nanotechnology for immunology , 2013, Nature Reviews Immunology.

[14]  R. Moldwin,et al.  Alternative therapies in the management of chronic prostatitis/chronic pelvic pain syndrome , 2013, World Journal of Urology.

[15]  J. Nickel,et al.  National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI) symptom evaluation in multinational cohorts of patients with chronic prostatitis/chronic pelvic pain syndrome. , 2013, European urology.

[16]  Aaron J. Martin,et al.  Microparticles bearing encephalitogenic peptides induce T-cell tolerance and ameliorate experimental autoimmune encephalomyelitis , 2012, Nature Biotechnology.

[17]  C. Liao,et al.  Serum C-reactive protein levels are associated with residual urgency symptoms in patients with benign prostatic hyperplasia after medical treatment. , 2011, Urology.

[18]  J. Jarrell,et al.  Bedside Testing for Chronic Pelvic Pain: Discriminating Visceral from Somatic Pain , 2011, Pain research and treatment.

[19]  Z. Meng,et al.  Effect of surgical castration on expression of TRPM8 in urogenital tract of male rats , 2011, Molecular Biology Reports.

[20]  N. Vasdev,et al.  Chronic Prostatitis / Chronic Pelvic Pain Syndrome , 2008 .

[21]  Aaron J. Martin,et al.  Tolerance Induced by Apoptotic Antigen-Coupled Leukocytes Is Induced by PD-L1+ and IL-10–Producing Splenic Macrophages and Maintained by T Regulatory Cells , 2011, The Journal of Immunology.

[22]  J. Carbone,et al.  Immunological risk factors for infection after immunosuppressive and biologic therapies , 2011, Expert review of anti-infective therapy.

[23]  K. Herold,et al.  Immunotherapy of type 1 diabetes: where are we and where should we be going? , 2010, Immunity.

[24]  Xiaojing Ma,et al.  Regulation of interleukin-10 gene expression in macrophages engulfing apoptotic cells. , 2010, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[25]  J. Jarrell.  Demonstration of Cutaneous Allodynia in Association with Chronic Pelvic Pain , 2009, Journal of visualized experiments : JoVE.

[26]  A. Kanematsu,et al.  Voided stain on paper method for analysis of mouse urination , 2008, Neurourology and urodynamics.

[27]  N. Sawada,et al.  Differential expression profile of cold (TRPA1) and cool (TRPM8) receptors in human urogenital organs. , 2008, Urology.

[28]  D. Shoskes.  Chronic Prostatitis/Chronic Pelvic Pain Syndrome , 2008 .

[29]  M. Pontari,et al.  Mechanisms in prostatitis/chronic pelvic pain syndrome. , 2008, The Journal of urology.

[30]  S. Miller,et al.  Antigen-specific tolerance strategies for the prevention and treatment of autoimmune disease , 2007, Nature Reviews Immunology.

[31]  Giuseppe Penna,et al.  Spontaneous and Prostatic Steroid Binding Protein Peptide-Induced Autoimmune Prostatitis in the Nonobese Diabetic Mouse1 , 2007, The Journal of Immunology.

[32]  V. Rivero,et al.  Autoimmune etiology in chronic prostatitis syndrome: an advance in the understanding of this pathology. , 2007, Critical reviews in immunology.

[33]  M. Resnick,et al.  Experimental rodent models of prostatitis: limitations and potential , 2007, Prostate Cancer and Prostatic Diseases.

[34]  A. Schaeffer.  Chronic Prostatitis and the Chronic Pelvic Pain Syndrome , 2006 .

[35]  M. Ciol,et al.  Pain sensitization in male chronic pelvic pain syndrome: why are symptoms so difficult to treat? , 2003, The Journal of urology.

[36]  J. Krieger,et al.  Epidemiology of prostatitis: new evidence for a world-wide problem , 2003, World Journal of Urology.

[37]  V. Rivero,et al.  Prostatein or steroid binding protein (PSBP) induces experimental autoimmune prostatitis (EAP) in NOD mice. , 2002, Clinical immunology.

[38]  A. Schaeffer.  Quality of Life Is Impaired in Men With Chronic Prostatitis. The Chronic Prostatitis Collaborative Research Network , 2002 .

[39]  M. Litt,et al.  Interleukin-10 levels in seminal plasma: implications for chronic prostatitis-chronic pelvic pain syndrome. , 2002, The Journal of urology.

[40]  J. Nickel,et al.  Prevalence of prostatitis-like symptoms in a population based study using the National Institutes of Health chronic prostatitis symptom index. , 2001, The Journal of urology.

[41]  M. Altmannsberger,et al.  Immunocytological Analysis of Leukocyte Subpopulations in Urine Specimens before and after Prostatic Massage , 2001, European Urology.

[42]  P. Yarnold,et al.  IL-1beta and TNF-alpha in prostatic secretions are indicators in the evaluation of men with chronic prostatitis. , 2000, The Journal of urology.

[43]  J. Hebel,et al.  Elevated levels of proinflammatory cytokines in the semen of patients with chronic prostatitis/chronic pelvic pain syndrome. , 1998, Urology.

[44]  R. Alexander,et al.  Autoimmune prostatitis: evidence of T cell reactivity with normal prostatic proteins. , 1997, Urology.

[45]  J. Heiman,et al.  Sickness impact of chronic nonbacterial prostatitis and its correlates. , 1996, The Journal of urology.

[46]  P. Humphrey,et al.  Development of a mouse model for nonbacterial prostatitis. , 1994, The Journal of urology.

[47]  R. Iskandar,et al.  C‐Reactive Protein in Semen and Serum of Men with Chronic Prostatitis , 2009, Andrologia.

[48]  W. Dixon,et al.  Efficient analysis of experimental observations. , 1980, Annual review of pharmacology and toxicology.